# Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical Cancer

> **NCT05189028** · PHASE3 · UNKNOWN · sponsor: **Chuangzhen Chen** · enrollment: 290 (estimated)

## Conditions studied

- Cervical Cancer
- Neoadjuvant Chemotherapy

## Interventions

- **DRUG:** gemcitabine and cisplatin

## Key facts

- **NCT ID:** NCT05189028
- **Lead sponsor:** Chuangzhen Chen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-01
- **Primary completion:** 2025-06
- **Final completion:** 2025-06
- **Target enrollment:** 290 (ESTIMATED)
- **Last updated:** 2024-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05189028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05189028, "Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05189028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*